Market Cap | ₹2,549Cr |
ROE | 8.79% |
P/E Ratio(TTM) | 31.78 |
EPS(TTM) | 24.73 |
P/B Ratio | 2.89 |
Dividend Yield | 0.35% |
Industry P/E | 66.49 |
Book Value | 272.16 |
Debt to Equity | 0.23 |
Face Value | 5 |
Parent Organisation | Krsnaa Diagnostics |
Managing Director | Ms. Pallavi Bhatevara |
NSE Symbol | KRSNAA |
FUND NAME | AUM(%) |
---|---|
Tata Small Cap Fund Direct Growth | 1.91% |
Bandhan Small Cap Fund Direct Growth | 0.31% |
Tata India Pharma & Healthcare Fund Direct Growth | 0.09% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Dr Lal PathLabs | NA (0.00%) | 54.07 | ||
Metropolis Healthcare | NA (0.00%) | 74.67 | ||
Vijaya Diagnostic Centre | NA (0.00%) | 68.94 | ||
Thyrocare Technologies | NA (0.00%) | 62.99 |